Press Releases Qiagen N.V.

Equities

QGEN

NL0015001WM6

Delayed Nyse Other stock markets 21:00:02 18/06/2024 BST			5-day change	1st Jan Change
43.75 ^USD	+0.05%		-0.48%	-2.29%

04:20pm	Sartorius on the downswing again - low since 2020 is approaching	DP
01:45pm	Invest Securities Raises Qiagen PT, Maintains Neutral Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

QIAGEN announces 2028 strategy for solid profitable growth	06-17	AQ
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs	06-13	AQ
QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth	06-12	AQ
Qiagen N : 2023 Sustainability Report	06-12	PU
Qiagen N : Sustainability Report 2023	06-12	PU
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance	06-11	AQ
QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period	06-06	AQ
QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe	06-05	AQ
Qiagen N : 2023 Annual Report Insights Magazine 2024	06-03	PU
Qiagen N : 2023 Conflict mineral statement	06-03	PU
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care	06-03	AQ
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications	05-30	AQ
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine	05-29	AQ
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support	05-14	AQ
Qiagen N : 2023 Annual Report 2023 Sustainability Statement	05-13	PU
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results	05-13	AQ
Qiagen N : 2024 QIAGEN N.V. Annual General Meeting of Shareholders Presentation	05-08	PU
Qiagen N : 2023 Annual Report 2023 Annual Financial Report	05-08	PU
Qiagen N : Annual Report 2023, including the Reports of the Managing Board and the Supervisory Board of N.V.	05-07	PU
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics	05-07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 02:32 pm